Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months.
about
Safety and Efficacy of Microinvasive Glaucoma SurgeryMinimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma.Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis.Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes.Prospective Evaluation of Two iStent® Trabecular Stents, One iStent Supra® Suprachoroidal Stent, and Postoperative Prostaglandin in Refractory Glaucoma: 4-year Outcomes.Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma.
P2860
Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@en
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@nl
type
label
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@en
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@nl
prefLabel
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@en
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@nl
P2093
P2860
P1476
Newly Diagnosed Primary Open-A ...... n: Outcomes Through 36 Months.
@en
P2093
Hady Saheb
Imran Masood
Iqbal Ike K Ahmed
Lilit Voskanyan
Manfred Tetz
Steven D Vold
P2860
P2888
P304
P356
10.1007/S40123-016-0065-3
P577
2016-09-12T00:00:00Z